Literature DB >> 17080390

Comparative cost of selective screening to prevent transmission of methicillin-resistant Staphylococcus aureus (MRSA), compared with the attributable costs of MRSA infection.

Laura Gavaldà1, Cristina Masuet, Juan Beltran, Maria Garcia, Delia Garcia, Josep M Sirvent, Josep M Ramon.   

Abstract

The annual cost of a screening program to detect methicillin-resistant Staphylococcus aureus (MRSA) in a teaching hospital in Spain was 10,261 Euro. The average cost per MRSA infection was 2,730 Euro; therefore, the cost of the program would be covered if it only prevented 4 infections per year (11% of the total number of MRSA infections at our hospital).

Entities:  

Mesh：

Year:  2006        PMID： 17080390     DOI： 10.1086/507968

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  13 in total

Review 1.  Transmission rates, screening methods and costs of MRSA--a systematic literature review related to the prevalence in Germany.

Authors:  A Tübbicke; C Hübner; A Kramer; N-O Hübner; S Fleßa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-10       Impact factor: 3.267

2.  A selected screening programme was less effective in the detection of methicillin-resistant Staphylococcus aureus colonisation in an orthopaedic unit.

Authors:  Jayshree Dave; Paul J Jenkins; Alison Hardie; Melvyn Smith; Paul Gaston; Alan P Gibb; Kate Templeton; Alastair H Simpson
Journal:  Int Orthop       Date:  2013-09-08       Impact factor: 3.075

Review 3.  Costs of hospital-acquired infection and transferability of the estimates: a systematic review.

Authors:  H Fukuda; J Lee; Y Imanaka
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

4.  Cost-effectiveness of rapid MRSA screening in surgical patients.

Authors:  Marten Schulz; Claudia Nonnenmacher; Reinier Mutters
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-08-10       Impact factor: 3.267

5.  Nasal MRSA screening for surgical patients: predictive value for postoperative infections caused by MRSA.

Authors:  Yutaka Matsubara; Hideaki Uchiyama; Takahiro Higashi; Ai Edagawa; Hirokuni Ishii; Shigeyuki Nagata; Kenkichi Hashimoto; Daihiko Eguchi; Hirofumi Kawanaka; Toshirou Okuyama; Masahiro Tateishi; Daisuke Korenaga; Kenji Takenaka
Journal:  Surg Today       Date:  2013-07-04       Impact factor: 2.549

6.  Rapid screening for carriage of methicillin-resistant Staphylococcus aureus by PCR and associated costs.

Authors:  Manuela Bühlmann; Katja Bögli-Stuber; Sara Droz; Kathrin Mühlemann
Journal:  J Clin Microbiol       Date:  2008-04-30       Impact factor: 5.948

7.  Effect of methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit on total hospital cost.

Authors:  Eric D Schultz; David T Tanaka; Ronald N Goldberg; Daniel K Benjamin; P Brian Smith
Journal:  Infect Control Hosp Epidemiol       Date:  2009-04       Impact factor: 3.254

8.  Impact of active screening for methicillin-resistant Staphylococcus aureus (MRSA) and decolonization on MRSA infections, mortality and medical cost: a quasi-experimental study in surgical intensive care unit.

Authors:  Yuarn-Jang Lee; Jen-Zon Chen; Hsiu-Chen Lin; Hsin-Yi Liu; Shyr-Yi Lin; Hsien-Ho Lin; Chi-Tai Fang; Po-Ren Hsueh
Journal:  Crit Care       Date:  2015-04-08       Impact factor: 9.097

9.  Cost Analysis of an Intervention to Prevent Methicillin-Resistant Staphylococcus Aureus (MRSA) Transmission.

Authors:  Michal Chowers; Yehuda Carmeli; Pnina Shitrit; Asher Elhayany; Keren Geffen
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

10.  Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Virginia R Roth; Tara Longpre; Doug Coyle; Kathryn N Suh; Monica Taljaard; Katherine A Muldoon; Karamchand Ramotar; Alan Forster
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.